Lyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYRA and other ETFs, options, and stocks.About LYRA
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
CEOMaria Palasis
CEOMaria Palasis
Employees30
Employees30
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2005
Founded2005
Employees30
Employees30
LYRA Key Statistics
Market cap7.61M
Market cap7.61M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume154.38K
Average volume154.38K
High today$4.59
High today$4.59
Low today$4.26
Low today$4.26
Open price$4.50
Open price$4.50
Volume20.78K
Volume20.78K
52 Week high$37.50
52 Week high$37.50
52 Week low$2.84
52 Week low$2.84
Stock Snapshot
As of today, Lyra Therapeutics(LYRA) shares are valued at $4.27. The company's market cap stands at 7.61M, with a P/E ratio of -0.18.
As of 2025-12-05, Lyra Therapeutics(LYRA) stock has fluctuated between $4.26 and $4.59. The current price stands at $4.27, placing the stock +0.2% above today's low and -7.0% off the high.
Lyra Therapeutics(LYRA) shares are trading with a volume of 20.78K, against a daily average of 154.38K.
During the past year, Lyra Therapeutics(LYRA) stock moved between $2.84 at its lowest and $37.50 at its peak.
During the past year, Lyra Therapeutics(LYRA) stock moved between $2.84 at its lowest and $37.50 at its peak.
People also own
Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.